Skip to main content
Clinical Trials/NCT07409350
NCT07409350Not yet recruitingNot Applicable

A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs

NYU Langone Health3 sites in 1 country398 target enrollmentStarted: January 1, 2027Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
398
Locations
3
Primary Endpoint
Percentage of Participants with PrEP Uptake

Study Overview

Brief Summary

This study includes finalization of the LINKED social network intervention to improve PrEP and MOUD uptake among people who inject drugs (PWID) in collaboration with an Expert Advisory Board and staff (N=16) at The Sidewalk Project (TSP), followed by a Hybrid Type II cluster randomized trial of the LINKED intervention (versus an equal-attention control) among N=372 people who inject drugs, with 6- and 12-month follow-up assessment of PrEP and MOUD uptake. The investigators will also evaluate implementation outcomes to inform future sustainable implementation of LINKED in harm reduction organizations.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Aim 1 - Virtual Focus Group
  • Is 18 years or older
  • Is a current TSP staff
  • Is capable and willing to provide consent
  • Aim 2 - Intervention
  • 18 years or older
  • Spend majority of their time in the Los Angeles, CA area where recruited
  • Able to complete surveys and group sessions in English
  • Self-report to have injected drugs in the past 3 months
  • Self-reported HIV negative serostatus
  • Not currently on PrEP or MOUD
  • Not pregnant
  • If a network recruit: presents a valid recruitment coupon
  • Is capable and willing to provide consent
  • Aim 3 - Virtual Focus Group/Surveys
  • Is 18 years or older
  • Is a current TSP staff
  • Is capable and willing to provide consent

Exclusion Criteria

  • Aims 1 and 3:
  • Individuals who are not current TSP staff members will be excluded from participation.
  • Under age 18;
  • Does not spend majority of time in the Los Angeles, CA area where recruited;
  • Unable to complete surveys and groups sessions in English;
  • Does not self-report injecting drugs in past 3 months;
  • Self-reported HIV positive serostatus
  • Currently on PrEP or MOUD
  • Currently pregnant
  • If a network recruit: does not present a valid recruitment coupon

Arms & Interventions

LINKED Intervention

Experimental

Participants randomized to the LINKED arm will receive a peer change agent intervention consisting of a 3-hour workshop divided into four learning and practice modules.

Intervention: LINKED (Behavioral)

Equal-Attention Control

Active Comparator

Participants randomized to the equal attention control group will receive a group intervention facilitated by trained study staff.

Intervention: Group Intervention (Behavioral)

Outcomes

Primary Outcomes

Percentage of Participants with PrEP Uptake

Time Frame: Month 6

Measured via filled PrEP prescription.

Percentage of Participants with PrEP Uptake

Time Frame: Month 12

Measured via filled PrEP prescription.

Percentage of Participants with MOUD Uptake

Time Frame: Month 6

Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.

Percentage of Participants with MOUD Uptake

Time Frame: Month 12

Measured via filled MOUD prescription or buprenorphine, methadone, or naltrexone enrollment.

Percentage of Participants with PrEP Adherence

Time Frame: Month 6

Measured via urine immunoassays to test for oral PrEP.

Percentage of Participants with PrEP Adherence

Time Frame: Month 12

Measured via urine immunoassays to test for oral PrEP.

Percentage of Participants with MOUD Adherence

Time Frame: Month 6

Measured via urinalysis to test for metabolites for MOUD.

Percentage of Participants with MOUD Adherence

Time Frame: Month 12

Measured via urinalysis to test for metabolites for MOUD.

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials

A Social Network Approach to Improve HIV... | Clinical Trial